Balyasny Asset Management »

Bridgebio Pharma shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $35M 25M 1.40
2024-09-30 $35M 34M 1.03

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Select Sector Spdr Tr Financial (XLF)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A Call Option (V)
Wolfspeed Common Stock (WOLF)

View all positions for Balyasny Asset Management

Top funds holding Bridgebio Pharma

Wolverine Asset Management
Linden Advisors
Weiss Asset Management LP[1
Tenor Capital Management
Citadel Advisors
Graham Capital Management
Balyasny Asset Management
Ing Investment Management
Capstone Investment Advisors
Lazard Asset Management
683 Capital Management
Lord, Abbett & Co
M&G
Morgan Stanley
State Street Corporation

View all funds holding Bridgebio Pharma